Citadel Advisors’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79,249
| Closed | -$69K | – | 6533 |
|
|
2024
Q3 | $69K | Sell |
79,249
-57,836
| -42% | -$50.4K | ﹤0.01% | 5038 |
|
|
2024
Q2 | $136K | Sell |
137,085
-25,680
| -16% | -$25.4K | ﹤0.01% | 4823 |
|
|
2024
Q1 | $173K | Buy |
162,765
+48,880
| +43% | +$51.8K | ﹤0.01% | 4854 |
|
|
2023
Q4 | $154K | Buy |
+113,885
| New | +$154K | ﹤0.01% | 4721 |
|
|
2023
Q2 | – | Sell |
-87,858
| Closed | -$105K | – | 6273 |
|
|
2023
Q1 | $105K | Buy |
87,858
+50,587
| +136% | +$60.7K | ﹤0.01% | 4892 |
|
|
2022
Q4 | $60.8K | Buy |
+37,271
| New | +$60.8K | ﹤0.01% | 5211 |
|
|
2022
Q2 | – | Sell |
-11,639
| Closed | -$18K | – | 6658 |
|
|
2022
Q1 | $18K | Sell |
11,639
-83,696
| -88% | -$129K | ﹤0.01% | 6154 |
|
|
2021
Q4 | $133K | Buy |
95,335
+78,347
| +461% | +$109K | ﹤0.01% | 5742 |
|
|
2021
Q3 | $36K | Sell |
16,988
-12,401
| -42% | -$26.3K | ﹤0.01% | 6202 |
|
|
2021
Q2 | $81K | Sell |
29,389
-19,989
| -40% | -$55.1K | ﹤0.01% | 6050 |
|
|
2021
Q1 | $188K | Buy |
+49,378
| New | +$188K | ﹤0.01% | 5460 |
|
|
2020
Q4 | – | Sell |
-23,139
| Closed | -$39K | – | 5430 |
|
|
2020
Q3 | $39K | Sell |
23,139
-14,897
| -39% | -$25.1K | ﹤0.01% | 4432 |
|
|
2020
Q2 | $72K | Buy |
+38,036
| New | +$72K | ﹤0.01% | 4296 |
|
|
2020
Q1 | – | Sell |
-32,465
| Closed | -$154K | – | 5163 |
|
|
2019
Q4 | $154K | Buy |
32,465
+15,549
| +92% | +$73.8K | ﹤0.01% | 4200 |
|
|
2019
Q3 | $10K | Buy |
+16,916
| New | +$10K | ﹤0.01% | 4581 |
|
|
2019
Q2 | – | Sell |
-29,520
| Closed | -$54K | – | 4958 |
|
|
2019
Q1 | $54K | Buy |
+29,520
| New | +$54K | ﹤0.01% | 4213 |
|